Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

The role of revascularization versus medical therapy in patients with type 2 diabetes mellitus and coronary artery disease.

Page BJ, Kireyev D, Boden WE.

Curr Diab Rep. 2010 Feb;10(1):10-5. doi: 10.1007/s11892-009-0091-9.

PMID:
20425061
3.

PCI versus CABG for multivessel coronary disease in diabetics.

Tarantini G, Ramondo A, Napodano M, Favaretto E, Gardin A, Bilato C, Nesseris G, Tarzia V, Cademartiri F, Gerosa G, Iliceto S.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):50-8. doi: 10.1002/ccd.21757.

PMID:
19089938
4.

Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.

Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW; ARTS-II Investigators.

J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.

5.

Multivessel percutaneous coronary intervention: a new paradigm for a new century.

Morrison DA.

Minerva Cardioangiol. 2005 Oct;53(5):361-77. Review.

PMID:
16179881
6.

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.

Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, Roy PK, Hill P, Okabe T, Torguson R, Smith KA, Xue Z, Gevorkian N, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.

Circulation. 2007 Sep 11;116(11 Suppl):I200-6.

7.

Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease.

Lee MS, Yang T, Dhoot J, Iqbal Z, Liao H.

Am J Cardiol. 2010 Jun 1;105(11):1540-4. doi: 10.1016/j.amjcard.2010.01.009. Epub 2010 Apr 8.

PMID:
20494658
9.

Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.

Barsness GW, Gersh BJ, Brooks MM, Frye RL; BARI 2D Trial Investigators.

Am J Cardiol. 2006 Jun 19;97(12A):31G-40G. Epub 2006 Apr 17.

PMID:
16813736
10.

Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.

Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, Baumbach A, Angelini G, de Belder A, Oldroyd KG, Flather M, Roughton M, Nihoyannopoulos P, Bagger JP, Morgan K, Beatt KJ.

J Am Coll Cardiol. 2010 Feb 2;55(5):432-40. doi: 10.1016/j.jacc.2009.10.014.

11.

Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.

Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F, Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P.

Circulation. 2008 Dec 2;118(23):2374-81. doi: 10.1161/CIRCULATIONAHA.107.727099. Epub 2008 Nov 24.

12.

Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.

Sobel BE.

Coron Artery Dis. 2010 May;21(3):189-98. doi: 10.1097/MCA.0b013e3283383ebe. Review.

PMID:
20308880
13.
14.

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.

Banning AP, Westaby S, Morice MC, Kappetein AP, Mohr FW, Berti S, Glauber M, Kellett MA, Kramer RS, Leadley K, Dawkins KD, Serruys PW.

J Am Coll Cardiol. 2010 Mar 16;55(11):1067-75. doi: 10.1016/j.jacc.2009.09.057. Epub 2010 Jan 14.

15.

Revascularization in high risk patients: diabetes mellitus.

Cola C, Sabaté M.

Minerva Cardioangiol. 2007 Oct;55(5):557-77. Review.

PMID:
17912163
16.

[Bypass surgery versus percutaneous coronary intervention in patients with diabetes mellitus].

Dörr R.

Herz. 2010 May;35(3):182-90. doi: 10.1007/s00059-010-3342-2. German.

PMID:
20467930
17.

Coronary revascularization in multivessel disease. Which is better, stents or surgery?

Almeda FQ, Snell RJ.

Postgrad Med. 2005 Dec;118(6):11-7. Review.

PMID:
16382760
18.

Revascularization in the high-risk patient: multivessel disease.

Onuma Y, Daemen J, Kukreja N, Serruys P.

Minerva Cardioangiol. 2007 Oct;55(5):579-92. Review.

PMID:
17912164
19.

Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.

Sunagawa G, Komiya T, Tamura N, Sakaguchi G, Kobayashi T, Murashita T.

Ann Thorac Surg. 2010 Jun;89(6):1896-900; discussion 1900. doi: 10.1016/j.athoracsur.2010.02.080.

PMID:
20494045
20.

Current concepts on coronary revascularization in diabetic patients.

Roffi M, Angiolillo DJ, Kappetein AP.

Eur Heart J. 2011 Nov;32(22):2748-57. doi: 10.1093/eurheartj/ehr305. Epub 2011 Sep 4. Review.

PMID:
21893486

Supplemental Content

Support Center